Clincosm LogoSign in Get a demo

Lymphoma, Non-Hodgkin

Showing NaN - NaN of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (JNJ-75348780)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Birmingham, Alabama
  • +43 more
Jan 27, 2023

Lymphoma, Non-Hodgkin Trial in Worldwide (CC-99282, Rituximab, Obinutuzumab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Los Angeles, California
  • +86 more
Jan 23, 2023

Lymphoma, Non-Hodgkin Trial in Worldwide (Standard of Care, JCAR017)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Standard of Care
  • JCAR017
  • Phoenix, Arizona
  • +78 more
Jan 13, 2023

Lymphoma, Non-Hodgkin Trial in Worldwide (TAK-981, Rituximab)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Birmingham, Alabama
  • +58 more
Dec 7, 2022

Lymphoma, Non-Hodgkin Trial in Worldwide (Ibrutinib, Rituximab, Ifosfamide)

Terminated
Has Results
  • Lymphoma, Non-Hodgkin
  • Los Angeles, California
  • +76 more
Nov 7, 2022

Lymphoma, Non-Hodgkin Trial in Worldwide (CC-96673)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Minneapolis, Minnesota
  • +11 more
Nov 18, 2022

Lymphoma, Non-Hodgkin, Hodgkin Disease Trial in Worldwide (Relatlimab, Nivolumab)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • Hodgkin Disease
  • Phoenix, Arizona
  • +53 more
Aug 17, 2022

Lymphoma, Non-Hodgkin, Chronic Lymphocytic Leukemia Trial in Worldwide (JNJ-64264681, JNJ-67856633)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Chronic Lymphocytic Leukemia
  • Stony Brook, New York
  • +27 more
Aug 11, 2022

Lymphoma, Non-Hodgkin Trial in Worldwide (CC-99282, Obinutuzumab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • Boston, Massachusetts
  • +17 more
Aug 1, 2022

Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell Trial in Worldwide (Ibrutinib)

Enrolling by invitation
  • Lymphoma, B-Cell
  • +4 more
  • Burbank, California
  • +90 more
Mar 31, 2022

Lymphoma, Non-Hodgkin Trial in Worldwide (Copanlisib (Aliqopa, BAY80-6946))

Active, not recruiting
Has Results
  • Lymphoma, Non-Hodgkin
  • Copanlisib (Aliqopa, BAY80-6946)
  • Birmingham, Alabama
  • +100 more
Feb 10, 2022

Lymphoma, Non-Hodgkin Trial in France, Spain (CC-95775)

Completed
  • Lymphoma, Non-Hodgkin
  • Paris, France
  • +4 more
Jan 31, 2022

Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Worldwide (brentuximab vedotin)

No longer available
  • Disease, Hodgkin
  • +3 more
  • brentuximab vedotin
  • Stanford, California
  • +30 more
Sep 17, 2020

Lymphoma, Non-Hodgkin Trial in Worldwide (ABP 798, Rituximab)

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • ABP 798
  • Rituximab
  • Encinitas, California
  • +97 more
Aug 7, 2020

Lymphoma, Non-Hodgkin Trial in Worldwide (Venetoclax, Cyclophosphamide, Obinutuzumab)

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • Fullerton, California
  • +51 more
May 26, 2020

Lymphoma, Non-Hodgkin Trial in Worldwide (Inotuzumab ozogamicin, Rituximab, rituximab + gemcitabine)

Terminated
Has Results
  • Lymphoma, Non-Hodgkin
  • Inotuzumab ozogamicin
  • +3 more
  • Burbank, California
  • +176 more
Dec 19, 2018

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin Trial in Worldwide (SGN-40, , rituximab)

Terminated
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, Non-Hodgkin
  • Birmingham, Alabama
  • +65 more
Feb 6, 2015

Lymphoma, Non-Hodgkin Trial in Worldwide (Zevalin ([90]Y-ibritumomab tiuxetan, BAY86-5128), no treatment)

Completed
  • Lymphoma, Non-Hodgkin
  • Zevalin ([90]Y-ibritumomab tiuxetan, BAY86-5128)
  • no treatment
  • Antwerpen, Belgium
  • +94 more
Nov 26, 2008